Epicore Biosystems

Epicore Biosystems

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12M

Overview

Epicore Biosystems is pioneering the use of sweat as a diagnostic fluid through its proprietary wearable microfluidic sensor platform. The company has developed three primary solution areas: a real-time monitor for industrial heat stress and hydration (CH), a performance tracker for athletes (GX), and an FDA-registered collection system for clinical research (DP). As a private company, Epicore is leveraging partnerships with pharmaceutical firms, military organizations, and universities to validate its technology and expand into new applications like maternal health and muscle fatigue, positioning itself at the intersection of digital health, personalized monitoring, and non-invasive diagnostics.

Metabolic HealthHydrationNutritionHeat Stress

Technology Platform

Wearable microfluidic sweat sensors that continuously capture and analyze biomarkers (electrolytes, metabolites) in sweat, integrated with skin temperature and motion data for personalized health and performance insights.

Funding History

2
Total raised:$12M
Series A$12M
SeedUndisclosed

Opportunities

The growing focus on industrial worker safety and heat stress regulations creates a strong push for Epicore's real-time monitoring solutions.
Furthermore, the vast, untapped potential of sweat as a diagnostic fluid opens long-term opportunities in non-invasive chronic disease management and preventative health screening, supported by research partnerships.

Risk Factors

Key risks include the need for extensive clinical validation to establish sweat biomarkers as reliable proxies for blood-based diagnostics, driving adoption in cost-sensitive industrial and competitive consumer markets, and competing with larger tech and medtech firms developing non-invasive sensing technologies.

Competitive Landscape

Epicore competes in the broader wearable biosensor market against large consumer electronics firms (e.g., Apple, Fitbit) offering general wellness metrics and specialized sports tech companies. Its primary differentiation is its focus on continuous, molecular-level sweat analysis via microfluidics, a more complex approach than typical optical heart rate or activity sensors. In clinical research, it competes with other specialized sweat collection devices.